GGrantIndex
← Search

BICALUTAMIDE VERSUS LEUPROLIDE ACETATE: HORMONAL THERAPY FOR PROSTATE CANCER

$478M01FY2005RRNIH

Massachusetts General Hospital, Boston MA

Investigators

Linked publications & trials

View original record on NIH RePORTER →
BICALUTAMIDE VERSUS LEUPROLIDE ACETATE: HORMONAL THERAPY FOR PROSTATE CANCER · GrantIndex